Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Jan. 31, 2013	Jan. 31, 2012
Cash flows from operating activities:
Net (loss)	$ (3,541,877)	$ (85,988)
Net (loss) from discontinued operations	(291,255)	(3,022)
Net (loss) from continuing operations	(3,250,622)	(82,966)
Adjustments to reconcile net (loss) from continuing operations to cash provided by operating activities:
Depreciation and amortization	794,526	945,706
(Gain) on sale of assets	(9,250)
Bad debt expense	536
Deferred financing costs / debt discount	614,226	110,005
Accrued deferred fee	260,700
Deferred income tax	0
Goodwill impairment	2,226,837
Changes in assets and liabilities:
Accounts receivable	1,083,596
Inventories	(89,072)
Other current assets	105,533
Accounts payable	1,623,696
Deferred revenue	170,516
Accrued payroll and commissions	(408,577)
Taxes accrued and withheld	(14,097)
Accrued expenses	(199,784)
Other liabilities	(450)
Net cash provided by operating activities continuing operations	2,908,314
Net cash provided by operating activities discontinued operations	93,011
Net cash provided by operating activities	3,001,325
Cash flows from investing activities:
Purchase of property and equipment	(73,600)
Proceeds from sale of fixed assets	9,250
Proceeds from assets held for sale	816,667
Other assets	(538)
Net cash provided by (used in) investing activities continuing operations	751,779
Net cash provided by (used in) investing activities discontinued operations	408,333
Net cash provided by (used in) investing activities	1,160,112
Cash flows from financing activities:
Net borrowings of notes payable	0
Net payment of notes payable	0
Proceeds from term debt	0
Principal payments on term debt	(1,832,508)	(1,424,194)
Decrease in negative book cash balances	0
Net cash used in financing activities continuing operations	(1,832,508)
Net cash used in financing activities discontinued operations	(408,333)
Net cash used in financing activities	(2,240,841)
Net increase in cash and cash equivalents	1,920,596
Cash and cash equivalents at beginning of period	1,844,797
Cash and cash equivalents at end of period	3,765,393
Restated [Member]
Cash flows from operating activities:
Net (loss)		(85,988)
Net (loss) from discontinued operations		(3,022)
Net (loss) from continuing operations		(82,966)
Adjustments to reconcile net (loss) from continuing operations to cash provided by operating activities:
Depreciation and amortization		945,706
(Gain) on sale of assets		(1,241)
Bad debt expense		138,782
Deferred financing costs / debt discount		110,005
Accrued deferred fee		0
Deferred income tax		(30,257)
Goodwill impairment		0
Changes in assets and liabilities:
Accounts receivable		1,199,659
Inventories		(222,391)
Other current assets		(683,725)
Accounts payable		1,310,609
Deferred revenue		247,469
Accrued payroll and commissions		(224,681)
Taxes accrued and withheld		217,499
Accrued expenses		(840,466)
Other liabilities		(450)
Net cash provided by operating activities continuing operations		2,083,552
Net cash provided by operating activities discontinued operations		746,675
Net cash provided by operating activities		2,830,227
Cash flows from investing activities:
Purchase of property and equipment		(217,292)
Proceeds from sale of fixed assets		18,365
Proceeds from assets held for sale		0
Other assets		(2,460)
Net cash provided by (used in) investing activities continuing operations		(201,387)
Net cash provided by (used in) investing activities discontinued operations		(58,305)
Net cash provided by (used in) investing activities		(259,692)
Cash flows from financing activities:
Net borrowings of notes payable		20,000
Net payment of notes payable		(20,000)
Proceeds from term debt		37,280
Principal payments on term debt		(1,424,194)
Decrease in negative book cash balances		(1,153,931)
Net cash used in financing activities continuing operations		(2,540,845)
Net cash used in financing activities discontinued operations		0
Net cash used in financing activities		(2,540,845)
Net increase in cash and cash equivalents		29,690
Cash and cash equivalents at beginning of period		0
Cash and cash equivalents at end of period		$ 29,690